204 related articles for article (PubMed ID: 23391096)
1. Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.
Cline EN; Li MH; Choi SK; Herbstman JF; Kaul N; Meyhöfer E; Skiniotis G; Baker JR; Larson RG; Walter NG
Biomacromolecules; 2013 Mar; 14(3):654-64. PubMed ID: 23391096
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
[TBL] [Abstract][Full Text] [Related]
3. PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance.
Anbazhagan R; Muthusamy G; Krishnamoorthi R; Kumaresan S; Rajendra Prasad N; Lai JY; Yang JM; Tsai HC
Biotechnol Bioeng; 2021 Mar; 118(3):1213-1223. PubMed ID: 33289076
[TBL] [Abstract][Full Text] [Related]
4. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.
Marcinkowska M; Stanczyk M; Janaszewska A; Sobierajska E; Chworos A; Klajnert-Maculewicz B
Pharm Res; 2019 Sep; 36(11):154. PubMed ID: 31482205
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
6. PAMAM dendrimers: destined for success or doomed to fail? Plain and modified PAMAM dendrimers in the context of biomedical applications.
Labieniec-Watala M; Watala C
J Pharm Sci; 2015 Jan; 104(1):2-14. PubMed ID: 25363074
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of interactions between a PAMAM dendrimer-paclitaxel conjugate and a biomembrane.
He X; Lin M; Lu T; Qu Z; Xu F
Phys Chem Chem Phys; 2015 Nov; 17(44):29507-17. PubMed ID: 26256278
[TBL] [Abstract][Full Text] [Related]
8. Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics.
Tekade RK; Tekade M; Kumar M; Chauhan AS
Pharm Res; 2015 Mar; 32(3):910-28. PubMed ID: 25205461
[TBL] [Abstract][Full Text] [Related]
9. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
10. Insights into the mechanism of microtubule stabilization by Taxol.
Xiao H; Verdier-Pinard P; Fernandez-Fuentes N; Burd B; Angeletti R; Fiser A; Horwitz SB; Orr GA
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10166-10173. PubMed ID: 16801540
[TBL] [Abstract][Full Text] [Related]
11. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
13. Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules.
Bode CJ; Gupta ML; Reiff EA; Suprenant KA; Georg GI; Himes RH
Biochemistry; 2002 Mar; 41(12):3870-4. PubMed ID: 11900528
[TBL] [Abstract][Full Text] [Related]
14. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
Khandare JJ; Jayant S; Singh A; Chandna P; Wang Y; Vorsa N; Minko T
Bioconjug Chem; 2006; 17(6):1464-72. PubMed ID: 17105225
[TBL] [Abstract][Full Text] [Related]
15. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
16. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells.
Wang W; Xiong W; Zhu Y; Xu H; Yang X
J Biomed Mater Res B Appl Biomater; 2010 Apr; 93(1):59-64. PubMed ID: 20186802
[TBL] [Abstract][Full Text] [Related]
18. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
Risinger AL; Mooberry SL
Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening of microtubule-interacting drugs.
Bane SL; Ravindra R; Zaydman AA
Methods Mol Med; 2007; 137():281-8. PubMed ID: 18085236
[TBL] [Abstract][Full Text] [Related]
20. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.
Teow HM; Zhou Z; Najlah M; Yusof SR; Abbott NJ; D'Emanuele A
Int J Pharm; 2013 Jan; 441(1-2):701-11. PubMed ID: 23089576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
